Rhythm Pharmaceuticals to Participate in Upcoming Investor Conferences
Rhythm Pharmaceuticals will put its story in front of Wall Street next month, with its chair, president, and CEO...
No videos found.
Comirnaty Approved for Adults 65+ and High-Risk Individuals 5-64
FDA has approved Pfizer and BioNTech’s LP.8.1-adapted monovalent Comirnaty for adults 65 and older and for individuals 5 to...
Moonlake Reports Phase 3 Hidradenitis Suppurativa Results
Moonlake Immunotherapeutics reported 16-week results from its two identically designed Phase 3 VELA trials of sonelokimab in moderate-to-severe hidradenitis...
Leqembi IV Maintenance Dosing Approved in China for Alzheimer’s
China’s National Medical Products Administration has approved once-every-four-weeks intravenous maintenance dosing for Leqembi (lecanemab), following 18 months of 10...
MoonLake Reports VELA Phase 3 HS Results with Sonelokimab
MoonLake Immunotherapeutics reported week 16 readouts from its two pivotal Phase 3 trials in hidradenitis suppurativa. In VELA-1, sonelokimab...
Profusa and Medical University of Graz Announce Collaboration
Profusa has entered a commercial and clinical collaboration with Prof. Dr. Marianne Brodmann at the Medical University of Graz,...
Onconetix’s New Focus: Secures Financing, Ends Ocuvex Deal
Onconetix has closed a $12.9 million private placement comprising Series D convertible preferred stock and warrants, using the raise...
FDA Approves Evkeeza for Rare High Cholesterol in Children
FDA has expanded Evkeeza (evinacumab-dgnb) to children aged 1 to under 5 with homozygous familial hypercholesterolemia, completing a stepwise...
PrestoDoctor Expands Cannabis Telehealth to Connecticut
PrestoDoctor, a telemedicine platform focused on medical cannabis evaluations and a subsidiary of Dogecoin Cash, has expanded into Connecticut,...
Strategic Partnership to Accelerate Immunotherapy Innovation
OSE Immunotherapeutics has entered a strategic partnership with Inserm Transfert and Nantes University to source, mature, and industrialize early-stage...